CME Group CME Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.88B+14.0% | $1.65B+7.2% | $1.54B-9.1% | $1.69B+3.0% | $1.64B+7.7% | ||
| $570.4M-9.3% | $629.1M+11.3% | $565M+0.4% | $562.7M+5.3% | $534.3M-7.6% | ||
| $1.31B+28.5% | $1.02B+4.8% | $972.6M-13.9% | $1.13B+1.9% | $1.11B+17.0% | ||
| 69.7%+7.8pp | 61.8%-1.4pp | 63.3%-3.5pp | 66.7%-0.7pp | 67.5%+5.4pp | ||
| $43.6M-0.2% | $43.7M-0.7% | $44M0.0% | $44M+5.5% | $41.7M+2.5% | ||
| $201.2M-64.0% | $558.8M+173% | $204.4M+1.7% | $201M+46.9% | $136.8M-8.5% | ||
| $1.51B— | —— | $1.18B-11.5% | $1.33B+6.9% | $1.24B— | ||
| $356.6M-9.8% | $395.5M+47.0% | $269M-11.9% | $305.2M+5.8% | $288.6M+30.0% | ||
| $1.17B-4.2% | $1.22B+36.0% | $896.6M-11.4% | $1.01B+7.2% | $944.2M+4.0% | ||
| 62.1%-11.8pp | 73.9%+15.6pp | 58.3%-1.5pp | 59.8%+2.3pp | 57.5%-2.0pp | ||
| $3.18-1.9% | $3.24+30.1% | $2.49-11.4% | $2.81+7.3% | $2.62+9.2% | ||
| $1.39B+33.1% | $1.05B+4.7% | $999.48M-13.6% | $1.16B+1.9% | $1.13B+16.3% | ||
| 74.1%+10.6pp | 63.5%-1.5pp | 65%-3.3pp | 68.3%-0.8pp | 69.1%+5.1pp | ||
| $1.31B+28.5% | $1.02B+4.8% | $972.6M-13.9% | $1.13B+1.9% | $1.11B+17.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CME Group's revenue?
- CME Group (CME) generated $6.8B in revenue over the trailing twelve months, up 7.5% year over year.
- Is CME Group profitable?
- CME Group reported $4.3B in net income over the trailing twelve months, a 63.6% net margin.
- What is CME Group's earnings per share?
- CME Group's diluted EPS over the trailing twelve months is $11.72.
- Where does CME Group's income statement data come from?
- Every line is extracted from CME Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
